Ignite Creation Date:
2024-05-06 @ 3:04 PM
Last Modification Date:
2024-10-26 @ 1:42 PM
Study NCT ID:
NCT04518410
Status:
COMPLETED
Last Update Posted:
2023-07-27
First Post:
2020-08-17
Brief Title:
ACTIV-2 A Study for Outpatients With COVID-19
Sponsor:
National Institute of Allergy and Infectious Diseases NIAID
Organization:
National Institute of Allergy and Infectious Diseases NIAID
Organization Data
Organization:
National Institute of Allergy and Infectious Diseases NIAID
Class:
NIH
Study ID:
A5401ACTIV-2
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
National Institute of Allergy and Infectious Diseases NIAID
Lead Sponsor Class:
NIH
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| SAb Biotherapeutics Inc | INDUSTRY |
| Eli Lilly and Company | INDUSTRY |
| Advancing Clinical Therapeutics Globally for HIVAIDS and Other Infections | NETWORK |
| Brii Biosciences Limited | INDUSTRY |
| AstraZeneca | INDUSTRY |
| Sagent Pharmaceuticals | INDUSTRY |
| Synairgen Research Ltd | INDUSTRY |
| Bristol-Myers Squibb | INDUSTRY |